THE POLITICS AND POLICIES OF BLAs AND aBLAs

Legislative and Regulatory Developments Impacting the Biopharmaceutical Industry

June 28, 2022 8:15am

Hans Sauer
Deputy General Counsel VP of IP
BIO

Karin A. Hessler
Assistant General Counsel
Association for Accessible Medicines (AAM)

David E. Korn
Vice President, IP and Law
PhRMA

Moderator:

Susan Krumplitsch
Partner
DLA Piper